20
Participants
Start Date
March 31, 2010
Primary Completion Date
February 29, 2012
Study Completion Date
February 29, 2012
Pegylated Recombinant Human Arginase I
Weekly dose of PEG-BCT-100 for at least 8 weeks (or until disease progression) at 1600U/kg
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong, Hong Kong
Lead Sponsor
The University of Hong Kong
OTHER
Chinese University of Hong Kong
OTHER
Bio-Cancer Treatment International Limited
INDUSTRY